Transforming cervical cancer screening

Cervical cancer is the easiest female cancer to prevent with regular screening and follow-up care. However, current forms of testing and diagnosis are outdated and ineffective. 

The most common screening tool for cervical cancer, the Pap smear, is almost 100 years old. It’s also expensive, painful, time consuming from sample to diagnosis, and employs antiquated technology. 

Women around the world deserve disease screening that is accessible, affordable, accurate, and comfortable.

HeraFem is the smart solution.

Combining advanced spectroscopy methods with data insights and Artificial Intelligence algorithms, HeraFem delivers accurate cervical cancer diagnoses in real time.

With its early detection capabilities for precancers and disease progression, the continuous insights gained from data capture, and the lower costs it delivers, HeraFem benefits both patients and providers.